These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1407594)

  • 41. Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia.
    McColl MD; Omran A; Walker ID; Lowe GD
    Haemophilia; 1999 Mar; 5(2):124-6. PubMed ID: 10215961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).
    Smith DI; Swamy PM; Heffernan MP
    J Am Acad Dermatol; 2007 Jan; 56(1):e1-54. PubMed ID: 17190617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human intravenous immunoglobulin and its traceability.
    Nolan D; O'Connor MB; Lynch D; Breen K
    Ir Med J; 2009 May; 102(5):160-1. PubMed ID: 19623817
    [No Abstract]   [Full Text] [Related]  

  • 44. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.
    Uyttendaele H; Obadiah J; Grossman M
    J Drugs Dermatol; 2003 Jun; 2(3):337-41. PubMed ID: 12848120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myasthenia gravis presenting as a unilateral abducens nerve palsy.
    Feuer H; Jagoda A
    Am J Emerg Med; 2001 Sep; 19(5):410-2. PubMed ID: 11555800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous immunoglobulins and mucous membrane pemphigoid.
    Mignogna MD; Leuci S; Piscopo R; Bonovolontà G
    Ophthalmology; 2008 Apr; 115(4):752-752.e1. PubMed ID: 18387410
    [No Abstract]   [Full Text] [Related]  

  • 47. [High-dose immunoglobulins in children with Guillain-Barré syndrome].
    Shahar E; Brand N
    Harefuah; 1991 Oct; 121(7-8):225-8. PubMed ID: 1783308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Bonaventura I; Ponseti J; Arnau E; Matias-Guiu J; Codina Puiggros A
    Arch Intern Med; 1987 Feb; 147(2):207, 211. PubMed ID: 3813729
    [No Abstract]   [Full Text] [Related]  

  • 50. [Indications--intravenous immunoglobulins--IVIG].
    Etzioni A; Sherer Y; Carp H; Mimouni D; Achiron A; Goddard G; Catz U; Shoenfeld Y
    Harefuah; 2005 Nov; 144(11):799-804. PubMed ID: 16358657
    [No Abstract]   [Full Text] [Related]  

  • 51. Immune globulin and the shortage of plasma derivatives.
    Tecnologica; 1999 Feb; ():1, 3-8, 10. PubMed ID: 10848145
    [No Abstract]   [Full Text] [Related]  

  • 52. Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome.
    Young PK; Ruggeri SY; Galbraith S; Drolet BA
    Arch Dermatol; 2006 Feb; 142(2):247-8. PubMed ID: 16490861
    [No Abstract]   [Full Text] [Related]  

  • 53. [Open rhinophonia in adults: a rare manifestation of cranial polyneuritis].
    Heiser C; Willmann O; Bran G; Kern R; Hörmann K; Stuck BA
    HNO; 2010 Feb; 58(2):155-8. PubMed ID: 19774355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Call for guidelines for monitoring renal function and haematological variables during intravenous infusion of immunoglobulin in neurological patients.
    Bajaj NP; Henderson N; Bahl R; Stott K; Clifford-Jones RE
    J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):562-3. PubMed ID: 11561055
    [No Abstract]   [Full Text] [Related]  

  • 55. Apnea as a complication of intravenous immunoglobulin therapy in a neonate.
    Kumar A; Kapoor R; Basu S
    Indian J Pediatr; 2014 Dec; 81(12):1415. PubMed ID: 24944148
    [No Abstract]   [Full Text] [Related]  

  • 56. Passive transfer of hepatitis B surface antibodies from intravenous immunoglobulin.
    Freitas R; Sousa S; Cordeiro A; Godinho F
    Acta Reumatol Port; 2020; 45(2):155. PubMed ID: 32895359
    [No Abstract]   [Full Text] [Related]  

  • 57. Slowly progressive cranial nerve palsies.
    Warner GC; Gandhi M; Panizza B
    Med J Aust; 2006 Jun; 184(12):641-3. PubMed ID: 16803446
    [No Abstract]   [Full Text] [Related]  

  • 58. What is the significance of gender difference in myasthenia gravis?
    Gable KL; Hobson-Webb LD
    Muscle Nerve; 2021 Nov; 64(5):515-516. PubMed ID: 34383342
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoglobulin therapy.
    Finlayson JS; Tankersley DL
    Lancet; 1991 Oct; 338(8771):893-4. PubMed ID: 1681255
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapeutic use of immunoglobulins].
    Balint B; Ilić V; Taseski J; Andrić Z; Vucetić D
    Vojnosanit Pregl; 1999; 56(3):303-14. PubMed ID: 10518451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.